Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HAEMONETICS CORPHAE · Entity 3953 | Director | July 24, 2026 | July 28, 2026 |
| Integer Holdings CorpITGR · Entity 4016 | Director | May 20, 2026 | May 22, 2026 |
| Medtronic plcMDT · Entity 2888 | EVP & Group Pres, Cardiac&Vasc | November 03, 2020 | November 05, 2020 |
| iRhythm Holdings, Inc.IRTC · Entity 1499 | Director · President and CEO | February 24, 2021 | February 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HAEMONETICS CORP
Report date July 24, 2026 · Filed July 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,932 |
Reported balance
After 2026-07-24 transaction · row 1
1 source rowRow 1 · 2026-07-24 · Grant · Acquired 2,538 · Balance 17,932 F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
F2: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Integer Holdings Corp
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,322 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,967 · Balance 3,322 F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027.
Medtronic plc
Report date November 03, 2020 · Filed November 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 190,390 |
Reported balance
After 2020-11-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-03 · Tax withholding · Disposed 393 · Balance 190,390 F1: This balance increased by 220 shares due to exempt transactions such as dividend reinvestment. |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Family Trust | 250 |
Reported balance
Holding disclosure · report date 2020-11-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 250 |
| Ordinary SharesSEC Table I · non-derivative | IndirectBy Spouse | 4,104 |
Reported balance
Holding disclosure · report date 2020-11-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,104 |
Filing footnotes · ownership attribution and instrument terms
F1: This balance increased by 220 shares due to exempt transactions such as dividend reinvestment.
iRhythm Holdings, Inc.
Report date February 24, 2021 · Filed February 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,247 |
Reported balance
After 2021-02-24 transaction · row 1
1 source rowRow 1 · 2021-02-24 · Grant · Acquired 33,247 · Balance 33,247 F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 24, 2026 Filed Jul 28, 2026 20:54 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,538 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000313143-26-000103 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,932 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:52 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantCommon Stock | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001233311-26-000002 · wk-form4_1779483162.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,322 F1 · shares: Grant of restricted stock units ("RSUs") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 20:23 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,693 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-019593 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,394 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 23:08 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantCommon Stock | 1,355 | $0.00 | $0.00 |
DisclosureSEC source: 0001114483-25-000128 · wk-form4_1752534484.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,355 F1 · shares: Grant of restricted stock units ("RSUs") as of July 10, 2025. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 21, 2025, November 21, 2025, February 21, 2026 and May 19, 2026. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:29 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021038 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,701 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| August 04, 2023 Filed Aug 8, 2023 20:29 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,226 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-022200 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,494 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 21:27 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 2,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-020697 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,268 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 23:18 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 3,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-023393 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,538 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:19 UTC | iRhythm Holdings, Inc. IRTC · Entity 1499 | GrantCommon Stock | 33,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001388658-21-000041 · wf-form4_161438866349642.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 22:53 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 393 | $103.13 | $40,530.09 |
DisclosureSEC source: 0001127602-20-028274 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,390 F1 · balance_after: This balance increased by 220 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 22:44 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 21,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026952 · form4.xml · derivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,164 Underlying: Performance Share Units · 21,164 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,164 shares will be issued. The actual number of shares to be issued could range from a low of 4,233 at minimum performance to a high of 42,328 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 49,118 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022893 · form4.xml · derivative · entry 6 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,118 Underlying: Ordinary Shares · 49,118 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022893 · form4.xml · derivative · entry 5 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 86,901 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022893 · form4.xml · derivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,901 Underlying: Ordinary Shares · 86,901 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:52 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022893 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,563 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:33 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,922 | $96.48 | $764,314.56 |
DisclosureSEC source: 0001127602-20-022588 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,110 F1 · balance_after: This balance increased by 770 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 21:17 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 1,983 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-021977 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,461 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. F3 · balance_after: This number includes unvested RSUs previously reported. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 20:30 UTC | HAEMONETICS CORP HAE · Entity 3953 | GrantCommon Stock | 478 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-014079 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478 F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:31 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 36,874 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-19-033063 · form4.xml · derivative · entry 7 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 36,874 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:31 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,797 | $112.07 | $425,529.79 |
DisclosureSEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,262 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.98 to $112.15, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:31 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 25,710 | $111.31 | $2,861,882.94 |
DisclosureSEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 3 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,059 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.96 to $111.88, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:31 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 7,367 | $110.59 | $814,679.70 |
DisclosureSEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 2 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,769 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.96 to $110.96, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:31 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 36,874 | $38.81 | $1,431,079.94 |
DisclosureSEC source: 0001127602-19-033063 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,202 | $0.00 Strike: $41.60 | $0.00 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · derivative · entry 8 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,202 shares Expires 2022-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 900 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · derivative · entry 7 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,874 Underlying: Ordinary Shares · 900 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,202 | $109.95 | $132,159.90 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,262 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,202 | $41.60 | $50,003.20 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 3 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 900 | $109.52 | $98,570.70 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 2 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,262 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 22:49 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 900 | $38.81 | $34,929.00 |
DisclosureSEC source: 0001127602-19-032879 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,202 | $0.00 Strike: $41.60 | $0.00 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · derivative · entry 8 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,202 Underlying: Ordinary Shares · 1,202 shares Expires 2022-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37,774 | $0.00 Strike: $38.81 | $0.00 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · derivative · entry 7 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,774 Underlying: Ordinary Shares · 37,774 shares Expires 2022-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,202 | $109.50 | $131,619.00 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · nonDerivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,262 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,202 | $41.60 | $50,003.20 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · nonDerivative · entry 3 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 37,774 | $109.50 | $4,136,253.00 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · nonDerivative · entry 2 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,262 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 23:26 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 37,774 | $38.81 | $1,466,008.94 |
DisclosureSEC source: 0001127602-19-031732 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 243 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 22:10 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 22,128 | $102.37 | $2,265,243.36 |
DisclosureSEC source: 0001127602-19-025929 · form4.xml · nonDerivative · entry 2 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,019 Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 22:10 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,561 | $102.37 | $774,019.57 |
DisclosureSEC source: 0001127602-19-025929 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,147 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:45 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,615 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025552 · form4.xml · derivative · entry 5 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,615 Underlying: Ordinary Shares · 1,615 shares Expires 2029-07-29 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:45 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 99,045 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025552 · form4.xml · derivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,045 Underlying: Ordinary Shares · 99,045 shares Expires 2029-07-29 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 21:45 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 14,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025552 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,708 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 2,157 shares due to exempt transactions such as dividend reinvestment. F3 · balance_after: The number of shares beneficially owned includes 521 ordinary shares that were inadvertently omitted from Mr. Coyle's previous filings. The previously omitted shares were issued upon the conversion of 545 ordinary shares of Covidien plc that were held by Mr. Coyle at the time of the acquisition by Medtronic plc in January 2015. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 84,060 | $0.00 Strike: $34.88 | $0.00 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · derivative · entry 9 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 84,060 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 70,984 | $0.00 Strike: $37.53 | $0.00 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · derivative · entry 8 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 70,984 shares Expires 2020-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 23,175 | $0.00 Strike: $43.15 | $0.00 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · derivative · entry 7 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 23,175 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 145,544 | $95.50 | $13,899,160.91 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,180 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive. The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 84,060 | $34.88 | $2,932,012.80 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 3 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 70,984 | $37.53 | $2,664,029.52 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 2 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 22, 2018 Filed Aug 23, 2018 20:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 23,175 | $43.15 | $1,000,001.25 |
DisclosureSEC source: 0001127602-18-026096 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:29 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,585 | $90.48 | $686,290.80 |
DisclosureSEC source: 0001127602-18-024843 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,505 Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 19:44 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,695 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024238 · form4.xml · derivative · entry 5 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 Underlying: Ordinary Shares · 1,695 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 19:44 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 99,414 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024238 · form4.xml · derivative · entry 4 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,414 Underlying: Ordinary Shares · 99,414 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.